Company Performance: Strong earnings, revenue growth, and profitability typically lead to higher stock prices, while poor performance can decrease them.

Industry Trends: Positive trends in the pharmaceutical sector (where 006220.KO, i.e. Celltrion, operates) like increased healthcare spending or breakthroughs in biosimilars can boost the stock.

Regulatory Environment: Changes in regulations related to drug approvals, pricing, or intellectual property can significantly impact Celltrion's prospects and stock price.

Market Sentiment: Overall investor confidence and risk appetite affect stock valuations. A bullish market can lift most stocks, while a bearish one can depress them.

Competition: The intensity of competition in the biosimilar market and Celltrion's ability to maintain its market share influence investor perception.

Macroeconomic Factors: Interest rates, inflation, and economic growth rates can influence investment decisions and impact stock prices.

Currency Exchange Rates: Fluctuations in the Korean Won (KRW) relative to other currencies, particularly the US dollar, can affect Celltrion's international sales and profitability.

Global Health Crises: Events like pandemics can significantly impact demand for pharmaceutical products and affect the stock price.

Investor Expectations: Anticipations about Celltrion's future performance, new product launches, and strategic initiatives play a crucial role in valuation.

News and Announcements: Company-specific news like clinical trial results, partnership agreements, or regulatory approvals can trigger immediate stock price reactions.